A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MHC-I

Search Conditions:
Search Keyword : MHC-I
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: MHC-I
Appearance Frequency: 1169 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
major histocompatibility complex class I
(874 times)
Allergy and Immunology
(162 times)
NK (68 times)
CTL (50 times)
ER (38 times)
1987 Ontogeny of ovine lymphocytes. I. An immunohistological study on the development of T lymphocytes in the sheep embryo and fetal thymus.
MHC class I
(249 times)
Allergy and Immunology
(152 times)
NK (26 times)
MHC (23 times)
MHCII (18 times)
1989 Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection.
MHC class I molecules
(25 times)
Allergy and Immunology
(13 times)
NK (3 times)
CTL (2 times)
CTLs (2 times)
1995 Measuring interactions of MHC class I molecules using surface plasmon resonance.
major histocompatibility
(4 times)
Biochemistry
(2 times)
AS (1 time)
beta2m (1 time)
CTLs (1 time)
2006 Cloning and sequence analysis of the beta2-microglobulin transcript from flounder, Paralichthys olivaceous.
anti-MHC class I
(2 times)
Allergy and Immunology
(2 times)
beta 2m (1 time)
BMC (1 time)
1994 Antibodies directed against monomorphic and evolutionary conserved self epitopes may be generated in 'knock-out' mice. Development of monoclonal antibodies directed against monomorphic MHC class I determinants.
MHC class I antigens
(2 times)
Dermatology
(1 time)
IFN-gamma (1 time)
IR (1 time)
TNF-alpha (1 time)
1994 Expression of classical and non-classical MHC class I antigens in murine hair follicles.
MHC type I
(2 times)
Histocytochemistry
(1 time)
MHC (2 times)
C/F (1 time)
CS (1 time)
2011 Effects of eccentric and concentric training on capillarization and myosin heavy chain contents in rat skeletal muscles after hindlimb suspension.
myosin heavy chain
(2 times)
Physiology
(1 time)
HSP70 (1 time)
1996 Effect of vitamin E deprivation and exercise training on induction of HSP70.
major histocompatibility class I antigen complex
(1 time)
Science
(1 time)
IR (1 time)
1997 A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors.
10  major histocompatibilty complex
(1 time)
Allergy and Immunology
(1 time)
CDC (1 time)
mAbs (1 time)
2013 Activation of complement by monoclonal antibodies that target cell-associated beta₂-microglobulin: implications for cancer immunotherapy.
11  MHC class I-related
(1 time)
Science
(1 time)
MVBs (1 time)
2010 Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation.
12  MHC-I to engineered CD8, we observed that peptide-deficient H-2Ld
(1 time)
Allergy and Immunology
(1 time)
--- 1998 Direct binding of the MHC class I molecule H-2Ld to CD8: interaction with the amino terminus of a mature cell surface protein.
13  MHC-Ihi
(1 time)
Neoplasms
(1 time)
--- 1998 Increased sensitivity of adriamycin-selected tumor lines to CTL-mediated lysis results in enhanced drug sensitivity.
14  MHC-Ilo
(1 time)
Medicine
(1 time)
TAP (1 time)
TEIPP (1 time)
2016 TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
15  MHC-linked, polymorphic, class I
(1 time)
Allergy and Immunology
(1 time)
--- 2011 The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice.
16  mice with F
(1 time)
Allergy and Immunology
(1 time)
eRSV (1 time)
FI-RSV (1 time)
OMP (1 time)
2007 Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
17  molecules capable of presenting HIV antigens to the immune system
(1 time)
Microbiology
(1 time)
--- 2008 HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells.